The Competition Commission of India (CCI) on Tuesday approved Torrent Pharmaceuticals Ltd’s proposed acquisition of a stake in JB Chemicals and Pharmaceuticals, contingent upon certain voluntary modifications submitted by both companies
A new therapy developed by AstraZeneca and Daiichi Sankyo has demonstrated significant success in a major clinical trial targeting an aggressive and difficult-to-treat form of breast cancer, potentially paving the way for regulatory approval
The U.S. Food and Drug Administration (FDA) has authorized TEZSPIRE (tezepelumab-ekko) for the add-on maintenance therapy of poorly managed chronic rhinosinusitis with nasal polyps (CRSwNP) in adults and pediatric patients aged 12 years and above
The multi-specialty chain, Ahmedabad-based Shalby Hospital, decided to go for a big expansion plan establishing a pan India presence.
Pfizer has disclosed positive Phase 3 results from the HER2CLIMB-05 trial, which is an important advancement for patients with HER2-positive (HER2+) metastatic breast cancer (MBC)...
Supriya Lifescience, a global leader in Active Pharmaceutical Ingredients (APIs) with a cGMP-certification has been awarded the Maharashtra State Export Award by the Government of Maharashtra for excellence in export for the FY 2022–23 and 2023–24...
Marksans Pharma Limited, a major global pharmaceutical company based in Mumbai, has revealed a significant regulatory achievement for its UK operations.
Syngene International, a worldwide contract research, development, and manufacturing organization (CRDMO), has announced enhancements to its facilities aimed at expediting drug discovery and development processes, thereby assisting clients
Cloudnine Hospitals, one of the largest chains in India focusing on maternity and paediatric care, is in advanced talks to acquire Apollo Cradle and Children’s Hospital (ACCHL) in a deal of approximately Rs 1,500 crore, according to sources...
Boehringer Ingelheim got the green light from the U.S. Food and Drug Administration (FDA) for JASCAYD (nerandomilast) tablets, allowing the addition of a new oral drug to the treatment modalities of adult patients
.jpg)
.jpg)
, CDSCO.jpg)